Discovering Hope Every Day
The Largest Phase 0 Clinical Trials Program in the World
The Ivy Brain Tumor Center is a nonprofit translational research program that offers state-of-the-art clinical trials for patients with even the most aggressive brain tumors.
Brain Tumor Treatment at Ivy
The Ivy Brain Tumor Center is a leader in brain tumor research and treatment. The Ivy Center is located in Phoenix, Arizona, at Barrow Neurological Institute, the highest-volume operative brain tumor center in the U.S.
Whether benign or malignant, a brain tumor can be life-changing. The Ivy Center’s multidisciplinary team of healthcare professionals and scientists work to understand the molecular structure of each patient’s brain tumor to determine its pathology and the most effective treatment plan. Explore a variety of brain tumor types we treat.
Tumors we treat
As one of the world’s largest brain tumor treatment centers, the Ivy Center utilizes advanced therapies, state-of-the-art technology and innovative clinical trials to tailor each patient’s treatment plan to their individualized needs and circumstances. No two brain tumors are alike and each tumor requires a treatment regimen designed for its unique genetic composition.
While each patient’s brain tumor experience is different, those on the receiving end of the diagnosis share the overwhelming feelings of worry, fear and stress. No one should have to cope with a brain cancer diagnosis alone. We understand the uncertainty of your circumstances. Our team is here for you every step of the way.
Clinical Trials
Ivy Brain Tumor Center clinical trials play a pivotal role in developing new therapies and advancing treatment options that make a significant impact on patient outcomes. The Ivy Center operates the world’s largest Phase 0 clinical trials program in the world.
What are Phase 0 Clinical Trials?
Clinical trials test new drugs, equipment and treatments that have not yet been approved. Phase 0 clinical trials study whether new drugs reach the intended brain tumor target and have the desired effect. This allows us to quickly advance drugs that show promise while eliminating those that do not.
What to Expect
Based on a combination of clinical, demographic and tumor genetics criteria, eligible patients are welcomed to an in-person consultation with an Ivy Center Navigator, who will guide them through the clinical trial process.
Explore Current Trials
Our brain tumor clinical trials are designed with the goal of discovering a breakthrough in brain cancer treatment. Explore active clinical trials currently enrolling at the Ivy Brain Tumor Center.
Complete Trial Screening Today
Each Ivy clinical trial has unique enrollment criteria. If you want to learn whether you or a loved one may be eligible, please submit a free trial screening request here or call 602-406-8605 to speak to an Ivy Navigator.
Latest from Ivy
News
Ivy Brain Tumor Center’s Dr. Nader Sanai Named Arizona Bioscience Researcher of the Year
Dr. Nader Sanai, Director of the Ivy Brain Tumor Center, has been named the 2024 Arizona Bioscience Researcher of the Year by the Arizona Bioindustry Association. This prestigious honor recognizes Dr. Sanai’s pioneering efforts and unwavering dedication to advancing new therapies for brain tumor patients, breaking new ground in the fight against this challenging disease.
Blog
Brain Tumor Talk Ep. 6: Caring for the Caregiver
Join “Brain Tumor Talk” as Ivy Center Nurse Navigator Jacki Garcia shares practical advice for cancer caregivers on managing the emotional and physical challenges of caregiving. Jacki offers tips on self-care, mental health, and balancing responsibilities, helping caregivers prioritize their own well-being while caring for loved ones.
News
First patient dosed in Phase 3 Gliofocus Study for newly diagnosed glioblastoma patients at the Ivy Brain Tumor Center
The Ivy Brain Tumor Center announced that the first patient has been dosed in the pivotal Phase 3 Gliofocus Study. Gliofocus is an open-label, randomized Phase 3 trial that will compare the efficacy of niraparib, a PARP1/2 selective inhibitor, to temozolomide head-to-head in adult patients with newly diagnosed MGMT-unmethylated glioblastoma.
Blog
Young, Healthy and Living With Brain Cancer
Living with brain cancer, Marcus Jones faced the unthinkable when a sudden diagnosis turned his world upside down. As a young, active Ironman competitor, he never imagined he’d be battling an aggressive brain tumor. Through determination, support from his family, and participation in a groundbreaking clinical trial at the Ivy Brain Tumor Center, Marcus has defied the odds and continues to live life on his own terms. Read the full story!
Blog
Clinical Trials for Brain Cancer Because Giving Up Isn’t an Option
Carol Stevens, who faced a glioblastoma recurrence just six months after standard treatment, found new hope in a clinical trial at the Ivy Brain Tumor Center. With a tailored approach that utilized an experimental drug specific to her tumor’s genetics, Carol experienced significant progress, underscoring the trial’s personalized and innovative strategy. Her story highlights the crucial role of clinical trials in providing options where standard treatments fall short. Read her full story!
Videos
New Reasons For Hope After Brain Tumor Diagnosis
Police Officer Makes 1,500-Mile Journey to Ivy Center
